Literature DB >> 28693276

Examination of the predictive factors of the response to whole brain radiotherapy for brain metastases from lung cancer using MRI.

Shuri Aoki1,2, Tomonori Kanda1, Noriyuki Matsutani3, Nobuhiko Seki4, Masafumi Kawamura3, Shigeru Furui1, Hideomi Yamashita2.   

Abstract

Previous studies have been conducted on the prognostic factors for overall survival in patients with brain metastases (BMs) following whole brain radiotherapy (WBRT). However, there have been a small number of studies regarding the prognostic factors for the response of tumor to WBRT. The aim of the present study was to identify the predictive factors for the response to WBRT from the point of view of reduction of tumor using magnetic resonance imaging. A retrospective analysis of 62 patients with BMs from primary lung cancer treated with WBRT was undertaken. The effects of the following factors on the response to WBRT were evaluated: Age; sex; performance status; lactate dehydrogenase; pathology; existence of extracranial metastases; activity of extracranial disease; chemo-history; chest radiotherapy history; treatment term; γ-knife radiotherapy; diffusion weighted image signal intensity; tumor diameter; extent of edema and the edema/tumor (E/T) ratio. The association between the reduction of tumors and clinical factors was evaluated using logistic regression analysis. P<0.05 was considered to indicate a statistically significant difference. The overall response ratio of this cohort was 54.8%. In the univariate analysis, the response of tumors was associated with the presence of small cell lung carcinoma (SCLC; P=0.0007), an E/T ratio of ≥1.5 (P=0.048), and a median tumor diameter of <20 mm (P=0.014). In the multivariate analysis, the presence of SCLC [P=0.001; odds ratio (OR), 17.152), an E/T ratio of ≥1.5 (P=0.019; OR, 9.526), and the presence of extracranial metastases (P=0.031; OR, 4.875) were revealed to be independent predictive factors for the reduction of tumor. The following 3 factors were significantly associated with the response of tumors to WBRT: The presence of SCLC; an E/T ratio of ≥1.5; and the presence of extracranial metastases. The E/T ratio is a novel index that provides a simple and easy predictive method for use in a clinical setting.

Entities:  

Keywords:  brain metastases; lung cancer; magnetic resonance imaging; oligo-recurrence; predictive factor; response; whole brain radiotherapy

Year:  2017        PMID: 28693276      PMCID: PMC5494783          DOI: 10.3892/ol.2017.6264

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  39 in total

1.  Survival benefit of stereotactic radiosurgery for metastatic brain tumors in patients with controlled primary lesions and no other distant metastases.

Authors:  Yuzuru Niibe; Katsuyuki Karasawa; Osamu Nakamura; Nobusada Shinoura; Kouichirou Okamoto; Ryouji Yamada; Kouichi Fukino; Yoshiaki Tanaka
Journal:  Anticancer Res       Date:  2003 Sep-Oct       Impact factor: 2.480

2.  A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database.

Authors:  Paul W Sperduto; Brian Berkey; Laurie E Gaspar; Minesh Mehta; Walter Curran
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-10-10       Impact factor: 7.038

Review 3.  Indications and limitations of chemotherapy and targeted agents in non-small cell lung cancer brain metastases.

Authors:  Stefan Zimmermann; Rafal Dziadziuszko; Solange Peters
Journal:  Cancer Treat Rev       Date:  2014-04-08       Impact factor: 12.111

4.  Investigation of using diffusion-weighted magnetic resonance imaging to evaluate the therapeutic effect of esophageal carcinoma treatment.

Authors:  Lan Wang; Chun Han; Shuchai Zhu; Gaofeng Shi; Qi Wang; Hua Tian; Jie Kong; Andu Zhang
Journal:  Oncol Res Treat       Date:  2014-02-21       Impact factor: 2.825

Review 5.  Radiotherapeutic management of brain metastases: a systematic review and meta-analysis.

Authors:  May N Tsao; Nancy S Lloyd; Rebecca K S Wong; Eileen Rakovitch; Edward Chow; Normand Laperriere
Journal:  Cancer Treat Rev       Date:  2005-06       Impact factor: 12.111

6.  Value of magnetic resonance diffusion-weighted imaging for the prediction of radiosensitivity in nasopharyngeal carcinoma.

Authors:  Jinsheng Hong; Yiqi Yao; Yu Zhang; Tianlan Tang; Hao Zhang; Daoliang Bao; Yunbin Chen; Jianji Pan
Journal:  Otolaryngol Head Neck Surg       Date:  2013-07-24       Impact factor: 3.497

7.  Pretreatment prediction of brain tumors' response to radiation therapy using high b-value diffusion-weighted MRI.

Authors:  Yael Mardor; Yiftach Roth; Aharon Ochershvilli; Roberto Spiegelmann; Thomas Tichler; Dianne Daniels; Stephan E Maier; Ouzi Nissim; Zvi Ram; Jacob Baram; Arie Orenstein; Raphael Pfeffer
Journal:  Neoplasia       Date:  2004 Mar-Apr       Impact factor: 5.715

8.  Stereotactic radiosurgery for brain metastasis in non-small cell lung cancer.

Authors:  Yong Kyun Won; Ja Young Lee; Young Nam Kang; Ji Sun Jang; Jin-Hyoung Kang; So-Lyoung Jung; Soo Yoon Sung; In Young Jo; Hee Hyun Park; Dong-Soo Lee; Ji Hyun Chang; Yun Hee Lee; Yeon-Sil Kim
Journal:  Radiat Oncol J       Date:  2015-09-30

9.  Novel insights of oligometastases and oligo-recurrence and review of the literature.

Authors:  Yuzuru Niibe; Joe Y Chang
Journal:  Pulm Med       Date:  2012-08-22

10.  Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects.

Authors:  Yuzuru Niibe; Tetsuo Nishimura; Tetsuya Inoue; Katsuyuki Karasawa; Yoshiyuki Shioyama; Keiichi Jingu; Hiroki Shirato
Journal:  BMC Cancer       Date:  2016-08-19       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.